2,000
Participants
Start Date
January 1, 2025
Primary Completion Date
December 1, 2030
Study Completion Date
December 30, 2030
Myval Transcatheter Heart Valve
The Myval TAVR bioprothesis is a balloon-expandable THV developed by Meril Lifesciences, which has novel operator friendly design features to improve deliverability and aid precise deployment.
RECRUITING
Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck
Prof. Dr. med. Ingo Eitel
OTHER